DE68924155D1 - Verfahren zur herstellung von natürlichem hiv-glykoprotein 160. - Google Patents
Verfahren zur herstellung von natürlichem hiv-glykoprotein 160.Info
- Publication number
- DE68924155D1 DE68924155D1 DE68924155T DE68924155T DE68924155D1 DE 68924155 D1 DE68924155 D1 DE 68924155D1 DE 68924155 T DE68924155 T DE 68924155T DE 68924155 T DE68924155 T DE 68924155T DE 68924155 D1 DE68924155 D1 DE 68924155D1
- Authority
- DE
- Germany
- Prior art keywords
- producing natural
- hiv glycoprotein
- natural hiv
- glycoprotein
- iii451
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000003886 Glycoproteins Human genes 0.000 title abstract 2
- 108090000288 Glycoproteins Proteins 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- 239000012679 serum free medium Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
- C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
- C07K14/16—HIV-1 ; HIV-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/974—Aids related test
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- AIDS & HIV (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Element Separation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Physical Vapour Deposition (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23285988A | 1988-08-16 | 1988-08-16 | |
US07/362,548 US5116740A (en) | 1988-08-16 | 1989-06-07 | Method for producing native hiv gp160 |
PCT/US1989/003428 WO1990002196A1 (en) | 1988-08-16 | 1989-08-10 | Method for producing native hiv gp160 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68924155D1 true DE68924155D1 (de) | 1995-10-12 |
DE68924155T2 DE68924155T2 (de) | 1996-04-18 |
Family
ID=26926401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE68924155T Expired - Lifetime DE68924155T2 (de) | 1988-08-16 | 1989-08-10 | Verfahren zur herstellung von natürlichem hiv-glykoprotein 160. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5116740A (de) |
EP (1) | EP0394386B1 (de) |
KR (1) | KR900702045A (de) |
AT (1) | ATE127526T1 (de) |
AU (1) | AU638214B2 (de) |
DE (1) | DE68924155T2 (de) |
DK (1) | DK175733B1 (de) |
FI (1) | FI102684B1 (de) |
HK (1) | HK1000969A1 (de) |
WO (1) | WO1990002196A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5254457A (en) * | 1989-01-11 | 1993-10-19 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Monoclonal antibodies and method for identifying different aids-related viruses |
WO1991015238A1 (en) * | 1990-04-03 | 1991-10-17 | Genentech, Inc. | Methods and compositions for vaccination against hiv |
US7041293B1 (en) | 1990-04-03 | 2006-05-09 | Genentech, Inc. | HIV env antibodies |
AU9028791A (en) * | 1990-10-05 | 1992-04-28 | President And Fellows Of Harvard College | Detection and isolation of ligands |
US5864027A (en) * | 1993-06-07 | 1999-01-26 | Genentech, Inc. | HIV envelope polypeptides |
US5736317A (en) * | 1995-03-07 | 1998-04-07 | Akzo Nobel N.V. | Human T-cell line infected with HIV-2 which secretes a protein corresponding to native HIV-2 gp160 in an extracellular medium |
US6585979B1 (en) | 1996-07-08 | 2003-07-01 | Genentech, Inc. | HIV envelope polypeptides and immunogenic composition |
ZA975889B (en) * | 1996-07-08 | 1998-02-23 | Genentech Inc | HIV envelope polypeptides and vaccine. |
US20020155120A1 (en) * | 1996-07-10 | 2002-10-24 | Lowell George H. | Protein and peptide vaccines for inducing mucosal immunity |
CN1500806B (zh) * | 2002-11-14 | 2010-05-05 | 上海科华生物工程股份有限公司 | 一种HIV-1ɡp160膜蛋白及其制备方法和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4699785A (en) * | 1984-09-18 | 1987-10-13 | The Regents Of The University Of California | Cell line producing feline leukemia virus |
WO1990002567A1 (en) * | 1988-09-02 | 1990-03-22 | The Ohio State University Research Foundation | Virus-derived antigenic composition and its preparation and use |
-
1989
- 1989-06-07 US US07/362,548 patent/US5116740A/en not_active Expired - Lifetime
- 1989-08-10 DE DE68924155T patent/DE68924155T2/de not_active Expired - Lifetime
- 1989-08-10 WO PCT/US1989/003428 patent/WO1990002196A1/en active IP Right Grant
- 1989-08-10 KR KR1019900700768A patent/KR900702045A/ko not_active Application Discontinuation
- 1989-08-10 EP EP89909487A patent/EP0394386B1/de not_active Expired - Lifetime
- 1989-08-10 AU AU40687/89A patent/AU638214B2/en not_active Expired
- 1989-08-10 AT AT89909487T patent/ATE127526T1/de not_active IP Right Cessation
-
1990
- 1990-04-10 DK DK199000900A patent/DK175733B1/da not_active IP Right Cessation
- 1990-04-12 FI FI901879A patent/FI102684B1/fi active IP Right Grant
-
1997
- 1997-12-29 HK HK97102646A patent/HK1000969A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR900702045A (ko) | 1990-12-05 |
AU638214B2 (en) | 1993-06-24 |
FI102684B (fi) | 1999-01-29 |
FI901879A0 (fi) | 1990-04-12 |
HK1000969A1 (en) | 1998-05-15 |
EP0394386A1 (de) | 1990-10-31 |
AU4068789A (en) | 1990-03-23 |
ATE127526T1 (de) | 1995-09-15 |
EP0394386B1 (de) | 1995-09-06 |
US5116740A (en) | 1992-05-26 |
DK90090A (da) | 1990-04-10 |
WO1990002196A1 (en) | 1990-03-08 |
DE68924155T2 (de) | 1996-04-18 |
FI102684B1 (fi) | 1999-01-29 |
DK90090D0 (da) | 1990-04-10 |
DK175733B1 (da) | 2005-02-07 |
EP0394386A4 (en) | 1991-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE192653T1 (de) | Anwendungen von acemannan | |
DE68924155D1 (de) | Verfahren zur herstellung von natürlichem hiv-glykoprotein 160. | |
AU3332089A (en) | Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals | |
DE3174765D1 (en) | High titer production of hepatitis a virus | |
NO922953L (no) | Rekombinant fremstilt blodfaktorer og fremgangsmaate for ekspresjon av blodfaktorene, samt vacciniavirusrekombinanter | |
ATE6402T1 (de) | Verfahren zur herstellung von hepatitis b oberflaechenantigen. | |
AU2567888A (en) | Hiv peptides and methods for detection of hiv | |
BG44379A3 (en) | Method for preparing of 9- chlor- 1, 5- benzothiazepine derivatives | |
ATE123523T1 (de) | Expression von hiv1- und 2- polypeptiden und deren verwendung. | |
GR3018918T3 (en) | Artificial viral envelopes | |
AU7512287A (en) | Expression of human t-cell lymphotropic virus (htlv-iii)reve rse transcriptase and uses thereof | |
DK135588A (da) | Inaktivering af hiv i proteinholdige oploesninger ved hjaelp af phenoler | |
NL300073I1 (nl) | Vaccin. | |
DE68908843D1 (de) | Verfahren zur Herstellung von 4,6-Dimethyl-7-hydroxynonan-3-on. | |
ZA913909B (en) | Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type i(hiv-1)gpl20 and methods of use | |
ZA893085B (en) | Human immunodeficiency virus(hiv)env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals | |
DK0429587T3 (da) | Fremgangsmåde til fremstilling af et regulationsprotein af HIV-1 under anvendelse af den humane cellelinie TH4-7-5 | |
SE8605535L (sv) | Cellsystem, dess framstellning och anvendning | |
SU1797350A1 (ru) | Способ обнаружения вируса иммунодефицита человека | |
BG46747A3 (en) | Method for preparing of 1, 5- benzothiazepine derivatives | |
DE3871305D1 (de) | Verwendung von einer immunstimulanten biologisten substanz zur herstellung eines medikaments zur behandlung des menschlichen immunschwaechevirus. | |
SU1473286A1 (ru) | Способ получения 1,1,1-триэтоксигептана |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |